SPO-1 protein (73-107), Sm16-p73

General Information


DRACP ID  DRACP03829

Peptide Name   SPO-1 protein (73-107), Sm16-p73

Sequence  MDKYIRKEDLGMKMLDVAKILGRRIEKRMEYIAKK

Sequence Length  35

UniProt ID  O77234 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiparasitic



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C188H326N54O50S4

Absent amino acids  CFHNPQSTW

Common amino acids  K

Mass  487788

Pl  10.54

Basic residues  11

Acidic residues  6

Hydrophobic residues  10

Net charge  5

Boman Index  -9202

Hydrophobicity  -71.14

Aliphatic Index  92

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  2980

Absorbance 280nm  87.65

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23875042

Title  Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13416

DRACP is developed by Dr.Zheng's team.